Soluble Advanced Glycation End Product (sRAGE) Levels

Soluble Advanced Glycation End Product (sRAGE) Levels in Childhood Obesity

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06771986

Enrollment

Registered

2025-01-13

Start date

2023-02-02

Completion date

2024-01-01

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Patients

Keywords

Children, obesity, sRAGE

Brief summary

The aim of this study is to evaluate sRAGE levels in children with obesity and to determine the relationship between metabolic status and sRAGE levels in childhood obesity

Interventions

OTHERObservation

sRAGE levels were studied in three different groups

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to 18 Years

Healthy volunteers

Inclusion criteria

Clinical diagnosis of Obesity BMI over 95th percentile BMI z-score over 2

Exclusion criteria

Primary hyperlipidemia Primary liver disease Hypothyroidism Diabetes

Design outcomes

Primary

Measure	Time frame
Evaluation of sRAGE levels in obese and healthy participants	From enrollment to the end of at 6 months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026